Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: Case report

Journal of Chemotherapy

Volumn 13, Issue 6, 2001, Pages 653-657

  Calza, Leonardo ^a   Marinacci, G ^a   Manfredi, R ^a   Colangeli, V ^a   Fortunato, L ^a   Chiodo, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cutaneous localization; HIV infection; Liposomal amphotericin B; Pentamidine isethionate; Pentavalent antimony drugs; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTILEISHMANIAL AGENT; ANTIMONY DERIVATIVE; PENTAMIDINE ISETHIONATE;

ADULT; ARTICLE; CASE REPORT; ENDEMIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS COMPLICATION; MALE; OPPORTUNISTIC INFECTION; RECURRENT INFECTION; RELAPSE; SECONDARY PREVENTION; SKIN LEISHMANIASIS; SOUTHERN EUROPE; VISCERAL LEISHMANIASIS;

EID: 0035696413     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.6.653     Document Type: Article

References (24)

1. Leishmaniasis
2. Atypical leishmaniasis in a patient with human immunodeficiency virus
3. Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical and diagnostic features of 22 cases
4. Atypical, cutaneous leishmaniasis with suspected visceral involvement in a patient with severe HIV-related immunodeficiency
5. Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus
6. Visceral leishmaniosis in HIV-positive patients: Primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte count
7. Clinical manifestations of visceral leishmaniasis associated with HIV infection: A retrospective study of 91 French cases
8. Disseminated cutaneous leishmaniasis in an HIV-infected patient
9. Concurrent leishmaniasis and human immunodeficiency virus (HIV) infection: A study of 4 cases
10. American cutaneous leishmaniasis associated with HIV infection: Report of 4 cases
11. Mucocutaneous leishmaniasis and HIV
12. American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection
13. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection
14. Treatment of visceral leishmaniasis in HIV-infected patients: A randomized trial comparing meglumine antimoniate with amphotericin B
15. Practical guide for treatment of leishmaniasis
16. HIV viral load and response to antileishmanial chemotherapy in co-infected patients
17. Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: Report of two cases
18. Liposomal amphotericin B as a first line and secondary prophylactic treatment for visceral leishmaniasis in a patient with HIV
19. Prevention of parasitic infection (excluding toxoplasmosis) in immunocompromised patients
20. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients
21. Secondary prophylaxis for Leishmania infection in an HIV-positive patient
22. Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients
23. Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients
24. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia